Hirotsu, Y.; Schmidt-Edelkraut, U.; Nakagomi, H.; Sakamoto, I.; Hartenfeller, M.; Narang, R.; Soldatos, T.G.; Kaduthanam, S.; Wang, X.; Hettich, S.;
et al. Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide. Int. J. Mol. Sci. 2020, 21, 3895.
https://doi.org/10.3390/ijms21113895
AMA Style
Hirotsu Y, Schmidt-Edelkraut U, Nakagomi H, Sakamoto I, Hartenfeller M, Narang R, Soldatos TG, Kaduthanam S, Wang X, Hettich S,
et al. Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide. International Journal of Molecular Sciences. 2020; 21(11):3895.
https://doi.org/10.3390/ijms21113895
Chicago/Turabian Style
Hirotsu, Yosuke, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, Ikuko Sakamoto, Markus Hartenfeller, Ram Narang, Theodoros G. Soldatos, Sajo Kaduthanam, Xiaoyue Wang, Stephan Hettich,
and et al. 2020. "Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide" International Journal of Molecular Sciences 21, no. 11: 3895.
https://doi.org/10.3390/ijms21113895
APA Style
Hirotsu, Y., Schmidt-Edelkraut, U., Nakagomi, H., Sakamoto, I., Hartenfeller, M., Narang, R., Soldatos, T. G., Kaduthanam, S., Wang, X., Hettich, S., Brock, S., Jackson, D. B., & Omata, M.
(2020). Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide. International Journal of Molecular Sciences, 21(11), 3895.
https://doi.org/10.3390/ijms21113895